BN Business News
Add your company to Business Communicator →

Regulation & law · 15/11/2007

National Institutes of Health to Grant Exclusive Patent License for Prostatic Diseases Therapies

The National Institutes of Health is considering granting an exclusive patent license to practice certain inventions related to therapies for prostatic diseases, including patents and patent applications owned by BN ImmunoTherapeutics.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights